Askgene Pharma, Inc.

ACTIVE

5217 Verdugo Way Ste A, 加利福尼亚州文图拉县, California, United Stateswww.ask-gene.comSubsidiary11–50 employeesEstablished: 2012-01-01

Part of askgene ltd.

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2012

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

85.7%

Phase 3

14.3%

Trial Status Distribution

Active, not recruiting

28.6%

Completed

28.6%

Not yet recruiting

14.3%

Recruiting

28.6%

Clinical Trials

Trials sponsored by this organization (7)

ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma

Phase 3

Active, not recruiting

interventional

Jan 2024780 participants

ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.

Phase 1

Active, not recruiting

interventional

Feb 202362 participants

A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Phase 1

Completed

interventional

Feb 202356 participants

A Study of ASKG315 in Patients With Advanced Solid Tumors.

Phase 1

Recruiting

interventional

Oct 202256 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

Askgene Pharma, Inc.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (7)

ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma

A Study of ASKG712 in Patients With Diabetic Macular Edema

A Phase 1 Study of ASKG315 in Patients With Advanced Solid Tumors

A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.

ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.

A Study of ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

A Study of ASKG315 in Patients With Advanced Solid Tumors.

Approvals

News